You are here

Containment Valve Achieves Validated Nanogram Level Performance

The newest model in the ChargePoint PharmaSafe range of high containment valves has successfully achieved nanogram level performance. The PharmaSafe 'pro' patented split valve is specifically developed to meet the demands for operator protection against increasingly potent ingredients.

The PharmaSafe pro went through a set of containment performance test carried out by an independent third party. The testing was completed in accordance to the industry standard ISPE SMEPAC Guide: 'Assessing the Particulate Containment Performance of Pharmaceutical Equipment’. The tests have proven the PharmaSafe pro to achieve up to 0.1µg/cu m for the task duration.

The PharmaSafe pro utilizes a simple extraction process, which is integral to the valve, to minimize the volume of airborne contamination when the valve is separated, post transfer. The extraction system requirement is designed so that customers can commonly utilize existing onsite supply.

The patented split valve containment technology provides contained transfer of toxic ingredients, by providing a common interface at each process stage.